Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CGT Catapult’s cell and gene therapy manufacturing center has been officially opened by the Business Secretary Greg Clark and Science Minister Sam Gyimah.
read more
Agilent Technologies announced that it is breaking ground on a 15,000-square-foot expansion of the company’s logistics center in Cedar Creek, Texas.
read more
Telix Pharmaceuticals has selected Goodwin Biotechnology to optimize the process for cGMP manufacturing of its renal cancer imaging antibody drug conjugate TLX-250.
read more
STA Pharmaceutical announces that its API R&D and manufacturing facility located in Changzhou, China has secured Pre-Approval Inspection for two APIs from the FDA – with no Form 483s issued.
read more
Alcami announces the Missouri House of Representatives and St. Louis Mayor Lyda Krewson will honor Alcami with a resolution and letter of commendation.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Alcami Corporation announces the advancement of the drug development process with the company’s new, dramatically-reduced analytical testing turnaround times.
read more
TEDOR Pharma announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures.
read more
Vectalys and FlashCell have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
read more
Genvion has added to its contract development and manufacturing knowledge with the addition of new spray drying and Wurster coating technology.
read more
Bioasis and Wuxi Biologics announced an initial strategic collaboration for the development and manufacturing of xB3-001, Bioasis’ lead investigational biological candidate to treat brain cancer.
read more
AGC Biologics will supply bulk drug substance for the launch of Portola Pharmaceuticals' Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo].
read more
Stellar Biotechnologies announced that third-party trial results have demonstrated that the company's KLH manufacturing methods achieve robust viral clearance.
read more
Samsung BioLogics announced today that a third monoclonal antibody Drug Substance has been licensed by the FDA for its second plant.
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more